Zobrazeno 1 - 8 of 8 pro vyhledávání: '"R L, Korn"'
2
Iloprost Reduces Procoagulant Activity in the Extracorporeal Circuit
Autor: R. L. Korn, Jeevanandam, N. Stenach, Addonizio Vp, Carol A. Fisher
Publikováno v: Journal of Surgical Research. 55:433-440
Although activation of formed blood elements during cardiopulmonary bypass has been examined, its presumed procoagulant role has not been identified or quantified. We evaluated the effects of iloprost, an inhibitor of platelet and leukocyte function,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::692cc9223ef8b32820bc3c26868b05a1
https://doi.org/10.1006/jsre.1993.1165
Zobrazit plný text záznamu
3
Coaxial transthoracic fine-needle biopsy in patients with a history of malignant lymphoma
Autor: Michael D. Dake, Kent W. Nowels, D E Lucas, R M Walter, G R Wittich, R B Jeffrey, R L Korn
Publikováno v: Radiology. 183:175-178
Efficacy and safety of coaxial transthoracic fine-needle biopsy were evaluated in 54 patients with a history of malignant lymphoma and new chest lesions. Twenty-one patients had recurrent lymphoma. Correct diagnosis was made in 17 of the 21 patients
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e75765c5dbcd918b5f2134a47265a9e9
https://doi.org/10.1148/radiology.183.1.1549668
Zobrazit plný text záznamu
4
The effects of heparin bound surface modification (Carmeda Bioactive Surface) on human platelet alterations during simulated extracorporeal circulation
Autor: N, Stenach, R L, Korn, C A, Fisher, V, Jeevanandam, V P, Addonizio
Publikováno v: The journal of extra-corporeal technology. 24(3)
To determine if treatment with covalently bound heparin (Carmeda Bioactive Surface (CBAS)) to the synthetic surface of the extracorporeal circuit (ECC) would alter the stereotypic pattern of adverse platelet alterations, 450 ml of heparinized blood (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4bb408e9f24fc9502a424a5e060b7337
https://pubmed.ncbi.nlm.nih.gov/10148074
Zobrazit plný text záznamu
5
Phase Ib study of PR-104, a hypoxia-activated alkylating agent, in combination with gemcitabine (G) or docetaxel (D) in patients with advanced cancer
Autor: Mark J. McKeage, Teresa J. Melink, Ramesh K. Ramanathan, John Gutheil, Joseph G. Rajendran, Michael B. Jameson, R. L. Korn, N. S. Tchekmedyian
Publikováno v: Journal of Clinical Oncology. 26:3575-3575
3575 Background: PR-104 is a prodrug with selective toxicity to hypoxic tumor cells. In these cells, PR-104 forms a nitrogen mustard alkylator causing DNA crosslinks. Preclinical data suggest additive efficacy for PR-104 combined with G or D. This st
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fd1432b388ef874b932875399bd2e732
https://doi.org/10.1200/jco.2008.26.15_suppl.3575
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje